Holen Sie sich die Stockscreener-App
0.89
2.18%
0.019
Handel nachbörslich:
.89
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt EKSO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$0.871
Offen:
$0.875
24-Stunden-Volumen:
46,750
Relative Volume:
0.61
Marktkapitalisierung:
$19.58M
Einnahmen:
$18.28M
Nettoeinkommen (Verlust:
$-15.20M
KGV:
-0.7355
EPS:
-1.21
Netto-Cashflow:
$-12.21M
1W Leistung:
-7.31%
1M Leistung:
-14.42%
6M Leistung:
-32.06%
1J Leistung:
-23.93%
1-Tages-Spanne:
$0.87
$0.91
1-Wochen-Bereich:
$0.856
$1.00
52-Wochen-Spanne:
$0.83
$3.1285
Ekso Bionics Holdings Inc Stock (EKSO) Company Profile
Firmenname
Ekso Bionics Holdings Inc
Sektor
Telefon
510-984-1761
Adresse
101 GLACIER POINT, SAN RAFAEL
Ekso Bionics Holdings Inc Stock (EKSO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2016-10-14 | Eingeleitet | SunTrust | Buy |
Ekso Bionics Holdings Inc Aktie (EKSO) Neueste Nachrichten
StockNews.com Begins Coverage on Ekso Bionics (NASDAQ:EKSO) - Defense World
Lake Street Capital Has Lowered Expectations for Ekso Bionics (NASDAQ:EKSO) Stock Price - Defense World
Ekso Bionics Holdings Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Ekso Bionics reports lower Q3 sales amid optimism as Medicare reimbursements begin - North Bay Business Journal
H.C. Wainwright cuts Ekso Bionics target by 10%, maintains Buy on growth prospects - Investing.com India
Earnings call: Ekso Bionics announces mixed Q3 results, eyes future growth - Investing.com India
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q3 2024 Earnings Call Transcript - Insider Monkey
Boot Barn To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Ekso Bionics (EKSO) Reports Q3 Loss, Misses Revenue Estimates - MSN
Ekso Bionics Holdings Inc (EKSO) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
Ekso Bionics: Q3 Earnings Snapshot - The Advocate
Ekso Bionics Announces Third Quarter 2024 Financial Results - GlobeNewswire
Ekso Bionics earnings beat, revenue fell short of estimates By Investing.com - Investing.com Canada
Ekso Bionics Q3 2024 Earnings: EPS Beats Estimates at -$0.10, Re - GuruFocus.com
Ekso Bionics Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Ekso Bionics (NASDAQ:EKSO) Now Covered by StockNews.com - Defense World
Ekso Bionics (EKSO) to Release Quarterly Earnings on Monday - Defense World
Ekso Bionics Holdings (STU:23E2) Forward Dividend Yield % : 0.00% (As of Oct. 23, 2024) - GuruFocus.com
Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024 - The Manila Times
StockNews.com Initiates Coverage on Ekso Bionics (NASDAQ:EKSO) - Defense World
Exoskeleton Market Size to Hit USD 1863.61 Million by 2033 | Straits Research - GlobeNewswire Inc.
Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew Pinsky - GlobeNewswire
Human Augmentation Market Report 2024 Highlighting Rising - openPR
Speech Pathology Services Market Outlook: 2023 the Year on a Positive Note | Benchmark Therapies Inc, Dynatronics Corporation, Ekso Bionics Holdings Inc, GF health Products, Inc – Cauverynews - Cauverynews
Ekso Bionics (NASDAQ:EKSO) Now Covered by Analysts at StockNews.com - Defense World
TNR, The Niche Research says :Global Wearable Robotic Exoskeleton Market is Expected to Expand at a CAGR of 44.3% (2024 to 2034). This Growth Projection Covers Segments Including Type, Application, Functionality, Technology, End User,Region - Yahoo Finance
Esperion CEO Sheldon Koenig sells shares worth over $26k By Investing.com - Investing.com Canada
Esperion CEO Sheldon Koenig sells shares worth over $26k - Investing.com
BofA Securities Downgrades Esperion Therapeutics Inc. (ESPR) to an Underperform from a Neutral - Knox Daily
Stock Performance Spotlight: Esperion Therapeutics Inc. (ESPR) Ends the Day at 1.76, Down by -7.85 - The Dwinnex
EMINOVA HOLDINGS INTERNATIONAL signed a 1.5 M USD FUND RAISING AGREEMENT for "BIOREL KIDS FUN FOAM’ product - EIN News
National Bank of Canada FI Raises Stake in Esperion Therapeutics, Inc. (NASDAQ:ESPR) - Defense World
Ekso Bionics (NASDAQ:EKSO) Earns Hold Rating from Analysts at StockNews.com - Defense World
Speech Pathology Services Market Outlook: 2022 the Year on a Positive Note | Benchmark Therapies Inc, Dynatronics Corporation, Ekso Bionics Holdings Inc, GF health Products, Inc – Cauverynews - Cauverynews
Human Augmentation Market 2024 Growth factor – Samsung Electronics Co. Ltd.,Google LLC,Ekso Bionics Holdings Inc.,Garmin Ltd. – Cauverynews - Cauverynews
Ekso Bionics (NASDAQ:EKSO) Coverage Initiated by Analysts at StockNews.com - Defense World
Medical Exoskeleton Market to grow by USD 2.87 billion from 2024-2028, driven by rising spinal cord injury cases, AI-powered report- Technavio - The Malaysian Reserve
Ekso Bionics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits - Quantisnow
Ekso Bionics Holdings Inc (EKSO) Becoming More Attractive for Investors - Knox Daily
Medical Exoskeleton Market Statistical Forecast, Trade - openPR
SEC Form 424B4 filed by Ekso Bionics Holdings Inc. - Quantisnow
Ekso Bionics Announces Pricing of $6.0 Million Underwritten Public Offering - ForexTV.com
Investors Give Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Shares A 26% Hiding - Simply Wall St
Ekso Bionics (EKSO) Addressable Market to Grow on CMS Update - Yahoo Finance
Finanzdaten der Ekso Bionics Holdings Inc-Aktie (EKSO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
5.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):